Exchange: OTC·Updated 09:32 AM EDT

ERYFF Erytech Pharma - Ordinary Share

$0.0001
$0.0001
(0.00%)
Today
Mkt Cap$1.01M
Vol150.00

About ERYFF

PHAXIAM Therapeutics SA operates as a biopharmaceutical company. It engages in the development of treatments for resistant bacterial infections. The firm develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to combat bacterial infections in humans, particularly those resistant to antibiotics. The company was founded in 2004 and is headquartered in Lyon, France.
50

Neutral Sentiment

How do you feel about ERYFF?

Advertisement|Remove ads.